“Global Fertility Testing Devices Market” research covers Major Classifications, Applications, challenge and restraints for the key players. Global Fertility Testing Devices Market reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and sales, distribution and industry trends and revenue forecast information.
Global Fertility Testing Devices Market Product (Ovulation Prediction Kit & Fertility Monitor (Urine-Based, Saliva-Based, Basal Body Temperature)), Mode of Purchase (Over The Counter, Prescription Based.), End User, Geography- Industry Trends and Forecast to 2024.
Founded in 1837 and headquartered in Ohio, US. Proctor & Gamble is Consumer Goods Corporation. It has five segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. P&G Healthcare holds nearly 20% global market share.
Procter & Gamble has acquired a number of other companies that diversified its product line and significantly increased profits. Some of its acquisition include Folgers Coffee, Norwich Eaton Pharmaceuticals, Richardson-Vicks, Noxell (Noxzema), Shulton’s Old Spice, Max Factor, the Iams Company, and others. P&G operates in approximately 70 countries worldwide. It is present in North America, Europe, Latin America, Asia Pacific, Greater China and India, Middle East and Africa (IMEA).
In October 2017, P&G unveiled its new innovation in ovulation testing that pairs the accuracy of the Clearblue Ovulation Test, now with the app. The Clearblue Connected app will remind users when to test, display a user’s daily test results and let the user record details also.